322 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

300404

Boji Medical TechnologyLtd
CN¥7.42-0.5%-32.7%CN¥2.8bn/aPE96.8xn/a0.1%

600518

Kangmei Pharmaceutical
CN¥2.06-4.2%-3.7%CN¥28.6bn/aPS5.7xn/a0%

2022

Shanghai Kehua Bio-EngineeringLtd
CN¥7.56-4.9%-39.7%CN¥3.9bn/aPS1.6xn/a0%

710

Berry GenomicsLtd
CN¥8.44-6.9%-44.1%CN¥3.0bn/aPS2.5xn/an/a

2693

Hainan Shuangcheng Pharmaceuticals
CN¥5.55-7.8%-18.0%CN¥2.3bn/aPE210xn/a0%

688488

Jiangsu Aidea Pharmaceutical
CN¥16.00-4.4%35.0%CN¥6.7bn/aPS16.4xn/a0%

688221

Frontier Biotechnologies
CN¥6.70-4.3%-51.1%CN¥2.5bn/aPS22xn/an/a

300254

ShanXi C&Y Pharmaceutical GroupLTD
CN¥10.03-8.5%57.5%CN¥2.4bn/aPE96.2xn/a0%

603139

Shaanxi Kanghui Pharmaceutical
CN¥15.951.1%-7.6%CN¥1.6bn/aPS2.7xn/a0%

688426

Jiangsu CoWin Biotech
CN¥20.23-3.5%-42.4%CN¥2.3bn/aPS12.8xn/a2.1%

301075

Tibet Duo Rui Pharmaceutical
CN¥19.78-7.0%-25.7%CN¥1.6bn/aPE91.3xn/a0%

300683

Wuhan Hiteck Biological PharmaLtd
CN¥25.44-5.3%-33.1%CN¥3.3bn/aPS5.7xn/a0%

766

Tonghua Golden-Horse Pharmaceutical Industry CoLtd
CN¥17.39-7.0%228.7%CN¥16.8bn/aPE505.7xn/an/a

952

Hubei Guangji Pharmaceutical
CN¥5.94-1.3%-23.2%CN¥2.1bn/aPS2.7xn/a0%

504

Landfar Bio-medicine
CN¥7.82-6.6%-31.5%CN¥2.6bn/aPS17.4xn/an/a

300086

Honz Pharmaceutical
CN¥4.93-5.2%-20.9%CN¥2.2bn/aPS3.5xn/a0%

603716

Thalys Medical Technology Group
CN¥7.51-4.3%-27.4%CN¥1.4bn/aPB1xn/a0%

600624

Shanghai Fudan Forward S&T
CN¥4.48-4.9%-29.3%CN¥3.0bn/aPS4.2xn/a0%

813

Dezhan Healthcare
CN¥2.88-3.0%-14.8%CN¥6.2bn/aPS12.7xn/a0%

2581

Shandong Sinobioway Biomedicine
CN¥13.863.4%-23.8%CN¥9.1bn/aPS21.8xn/a0%

300966

Hubei Goto BiopharmLtd
CN¥16.17-6.7%-38.1%CN¥1.9bn/aPE80.9xn/a0%

603963

Dali Pharmaceuticalco.Ltd
CN¥10.201.5%-11.4%CN¥2.2bn/aPS21.3xn/a0%

2898

Sailong Pharmaceutical GroupLtd
CN¥10.72-3.2%1.8%CN¥1.9bn/aPS6.4xn/a0%

688197

Shouyao Holdings (Beijing)
CN¥51.516.4%-14.3%CN¥7.7bn/aPS1465xn/an/a
Page 13 of 14
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.